In addition to the lymphopenia induced by apoptosis in SARS-CoV-2 (46–49), researchers also observed the increased expression of T cell exhaustion markers, such as programmed cell death protein-1 (PD-1) and TIM-3 in peripheral blood of severe COVID-19 patients (44, 50). This evidence concerns the gene HAVCR2 and lymphopenia.